Thermo Fisher Scientific Stock BOERSE MUENCHEN
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
516.5 EUR | -0.65% | -3.99% | +8.15% |
08:00am | Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation | CI |
May. 24 | Declaration of Voting Results by Thermo Fisher Scientific Inc | CI |
Sales 2024 * | 43.02B 39.66B | Sales 2025 * | 46.1B 42.5B | Capitalization | 215B 198B |
---|---|---|---|---|---|
Net income 2024 * | 6.15B 5.67B | Net income 2025 * | 6.97B 6.43B | EV / Sales 2024 * | 5.54 x |
Net Debt 2024 * | 23.49B 21.66B | Net Debt 2025 * | 19.14B 17.64B | EV / Sales 2025 * | 5.07 x |
P/E ratio 2024 * |
35.3
x | P/E ratio 2025 * |
30.3
x | Employees | - |
Yield 2024 * |
0.27% | Yield 2025 * |
0.29% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 week | -3.99% | ||
Current month | -2.93% | ||
1 month | -2.93% | ||
3 months | -1.83% | ||
6 months | +14.39% | ||
Current year | +8.15% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-05-31 | 516.5 | -0.65% |
24-05-30 | 519.9 | -1.48% |
24-05-29 | 527.7 | +0.40% |
24-05-28 | 525.6 | -1.96% |
24-05-27 | 536.1 | -0.22% |
Real-time BOERSE MUENCHEN, May 31, 2024 at 12:44 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.90% | 187B | |
+17.61% | 143B | |
+28.91% | 110B | |
+1.48% | 64.68B | |
+13.70% | 52.96B | |
-0.16% | 49.84B | |
-4.97% | 38.32B | |
-0.23% | 35.86B | |
+19.96% | 30.75B |
- Stock Market
- Equities
- TMO Stock
- TN8 Stock